Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macronutrient balance" is not a molecule, receptor, or classical therapeutic target but rather a physiological and nutritional concept referring to the relative proportions of macronutrients (proteins, carbohydrates, and fats) in the diet and their metabolic effects. It plays a central role in maintaining energy homeostasis, influencing feeding behavior, satiety, and metabolic health. Regulation of macronutrient balance involves complex neuroendocrine pathways, including hormones such as FGF21 that affect macronutrient preference by acting on the brain and other tissues[1][2][3][5]. Disruption of macronutrient balance is associated with various disease states such as obesity, metabolic syndrome, and malnutrition[2][4][5]. Because "macronutrient balance" is not a discrete molecular entity but rather an abstract physiological concept, it is not classified as a therapeutic target, and there are no specific drugs or biomarkers directly targeting "macronutrient balance" itself in a molecular or pharmacological context[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macronutrient balance.